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Abstract
© 2017  Blatt,  Khaiboullin,  Lombardi,  Rizvanov  and  Khaiboullina.  Recent  discovery  of  an
association of low serum melatonin levels with relapse in multiple sclerosis (MS) opens a new
horizon in understanding the pathogenesis of this disease. Skin is the main organ for sensing
seasonal changes in duration of sunlight exposure. Level of melatonin production is dependent
on light exposure. The molecular mechanisms connecting peripheral (skin) sensing of the light
exposure and developing brain inflammation (MS) have not been investigated. We hypothesize
that there is a connection between the reaction of skin to seasonal changes in sunlight exposure
and  the  risk  of  MS  and  that  seasonal  changes  in  light  exposure  cause  peripheral  (skin)
inflammation, the production of cytokines, and the subsequent inflammation of the brain. In skin
of  genetically  predisposed  individuals,  cytokines  attract  memory  cutaneous  lymphocyte-
associated  antigen  (CLA+)  T  lymphocytes,  which  then  maintain  local  inflammation.  Once
inflammation is resolved, CLA+ lymphocytes return to the circulation, some of which eventually
migrate  to  the  brain.  Once  in  the  brain  these  lymphocytes  may initiate  an  inflammatory
response. Our observation of increased CC chemokine ligand 27 (CCL27) in MS sera supports
the involvement of skin in the pathogenesis of MS. Further, the importance of our data is that
CCL27 is a chemokine released by activated keratinocytes, which is upregulated in inflamed
skin. We propose that high serum levels of CCL27 in MS are the result of skin inflammation due
to exposure to seasonal changes in the sunlight. Future studies will determine whether CCL27
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